This is the authors' abstract. We don't add key points for this paper.
Decoding diverse molecular information, such as pathogen identity, single-nucleotide polymorphisms (SNPs), and antimicrobial resistance genes, typically requires complex probe designs and task-specific signal-decoupling strategies, thereby limiting analytical scalability. To address this challenge, a programmable molecular amplification evaluator (PMAE) was developed. PMAE is driven by an editable flap intermediate generated through the structure-specific recognition and cleavage activity of flap endonuclease 1 (FEN1). Acting as a target-independent molecular mediator, the flap decouples molecular recognition from downstream amplification by converting diverse recognition events into programmable DNA signals. These signals are subsequently propagated through a hierarchical cascade amplification network integrating the exponential amplification reaction (EXPAR) and a self-replicating DNA circuit (SDC), thereby establishing a coordinated framework linking molecular recognition, signal transformation, amplification, and output. By reprogramming the recognition primers, heterogeneous biomarkers are converted into standardized DNA signals while maintaining a unified signal-decoupling strategy. This modular design enables flexible reconfiguration for diverse DNA targets without altering the downstream amplification framework, overcoming the conventional application-tailored paradigm. The platform achieves attomolar (aM)-level sensitivity and single-nucleotide resolution without target pre-amplification, enabling the detection of Staphylococcus aureus ( S. aureus )-related molecular information within 40 min with high specificity, reproducibility, and stability. Furthermore, the platform demonstrates reliable analytical performance in spiked human throat swab and exhaled breath condensate (EBC) samples, supporting its potential for practical bioanalytical applications. This work establishes a programmable framework for integrated analysis of molecular identity, function, and risk, providing a scalable strategy for rapid pathogen biosensing with potential applications in early infectious disease surveillance and epidemiological investigations.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: